Chimeric Antigen Receptor T Cells (CART) Therapy in GUCY2C Positive Digestive System Tumors
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Chimeric antigen receptor T cell therapy-Innovative Cellular Therapeutics (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Gastric cancer; Gastrointestinal cancer; Liver cancer; Oesophageal cancer; Pancreatic cancer
- Focus Adverse reactions
- Acronyms ICT-GC
- Sponsors Innovative Cellular Therapeutics
- 10 Mar 2021 New trial record